Literature DB >> 7769661

Transactivation activity of Meq, a Marek's disease herpesvirus bZIP protein persistently expressed in latently infected transformed T cells.

Z Qian1, P Brunovskis, F Rauscher, L Lee, H J Kung.   

Abstract

Marek's disease virus (MDV) is an avian herpesvirus that induces a variety of diseases, including T-cell lymphomas, in chickens. In latently infected, transformed lymphoid cells, very few viral transcripts or proteins are detected. We previously described a gene, meq (MDV EcoQ), which is persistently expressed in MDV-transformed tumor samples and cell lines. meq codes for a 339-amino-acid protein with a basic-leucine zipper domain near its N terminus and a proline-rich domain near its C terminus. The basic-leucine zipper domain shows homology with Jun/Fos family proteins, whereas the proline-rich domain resembles that of the WT-1 tumor suppressor protein. These structural features raise the possibility that Meq functions as a transcription factor in regulating viral latency or oncogenesis. In this report, we show that the proline-rich domain is a potent transcription activator when fused to the yeast (Saccharomyces cerevisiae) Gal4(1-147) DNA-binding domain. The transactivation activity maps to the C-terminal 130 amino acids, with the last 33 amino acids essential. In the absence of these 33 amino acids, a two-and-one-half proline-rich repeat structure was found to exhibit repression activity. We further show that Meq is able to dimerize not only with itself but also with c-Jun. Meq/c-Jun heterodimers bind to an AP1-like sequence in the meq promoter region with an affinity much greater than that of Meq/Meq or c-Jun/c-Jun homodimers. Cotransfection chloramphenicol acetyltransferase assays suggest that the Meq/c-Jun heterodimers can up-regulate Meq expression in both chicken embryo fibroblasts and F9 cells. Our data provide the first biochemical evidence that Meq is a transcriptional factor and identify c-Jun as one of Meq's interacting partners.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769661      PMCID: PMC189137          DOI: 10.1128/JVI.69.7.4037-4044.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Genomic expansion of Marek's disease virus DNA is associated with serial in vitro passage.

Authors:  R F Silva; R L Witter
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

Review 2.  Marek's disease--a model for herpesvirus oncology.

Authors:  B W Calnek
Journal:  Crit Rev Microbiol       Date:  1986       Impact factor: 7.624

3.  Demonstration of Marek's disease tumor-associated surface antigen in chickens infected with nononcogenic Marek's disease virus and herpesvirus of turkeys.

Authors:  K A Schat; B W Calnek
Journal:  J Natl Cancer Inst       Date:  1978-09       Impact factor: 13.506

4.  Protection against Marek's disease by vaccination with a herpesvirus of turkeys.

Authors:  W Okazaki; H G Purchase; B R Burmester
Journal:  Avian Dis       Date:  1970-05       Impact factor: 1.577

5.  Inverted repeat nucleotide sequences in the genomes of Marek disease virus and the herpesvirus of the turkey.

Authors:  J Cebrian; C Kaschka-Dierich; N Berthelot; P Sheldrick
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

6.  The structure of Marek disease virus DNA: the presence of unique expansion in nonpathogenic viral DNA.

Authors:  K Fukuchi; A Tanaka; L W Schierman; R L Witter; M Nonoyama
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

7.  The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains.

Authors:  Z Y Wang; Q Q Qiu; T F Deuel
Journal:  J Biol Chem       Date:  1993-05-05       Impact factor: 5.157

8.  Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers.

Authors:  R L Witter; J M Sharma; L F Lee; H M Opitz; C W Henry
Journal:  Avian Dis       Date:  1984 Jan-Mar       Impact factor: 1.577

9.  Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa.

Authors:  T Henkel; P D Ling; S D Hayward; M G Peterson
Journal:  Science       Date:  1994-07-01       Impact factor: 47.728

10.  Different activation domains stimulate transcription from remote ('enhancer') and proximal ('promoter') positions.

Authors:  K Seipel; O Georgiev; W Schaffner
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  36 in total

1.  The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus.

Authors:  L F Lee; P Wu; D Sui; D Ren; J Kamil; H J Kung; R L Witter
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  The genome of a very virulent Marek's disease virus.

Authors:  E R Tulman; C L Afonso; Z Lu; L Zsak; D L Rock; G F Kutish
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication.

Authors:  Blanca Lupiani; Lucy F Lee; Xiaoping Cui; Isabel Gimeno; Amy Anderson; Robin W Morgan; Robert F Silva; Richard L Witter; Hsing-Jien Kung; Sanjay M Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

4.  Nuclear localization and dynamic properties of the Marek's disease virus oncogene products Meq and Meq/vIL8.

Authors:  Jonathan M Anobile; Vaithilingaraja Arumugaswami; Danielle Downs; Kirk Czymmek; Mark Parcells; Carl J Schmidt
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

5.  Novel DNA binding specificities of a putative herpesvirus bZIP oncoprotein.

Authors:  Z Qian; P Brunovskis; L Lee; P K Vogt; H J Kung
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

6.  Recombinant Marek's disease virus (MDV)-derived lymphoblastoid cell lines: regulation of a marker gene within the context of the MDV genome.

Authors:  M S Parcells; R L Dienglewicz; A S Anderson; R W Morgan
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

7.  Activation domain requirements for disruption of Epstein-Barr virus latency by ZEBRA.

Authors:  S Asković; R Baumann
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  CCAAT/enhancer binding protein alpha binds to the Epstein-Barr virus (EBV) ZTA protein through oligomeric interactions and contributes to cooperative transcriptional activation of the ZTA promoter through direct binding to the ZII and ZIIIB motifs during induction of the EBV lytic cycle.

Authors:  Frederick Y Wu; Shizhen Emily Wang; Honglin Chen; Ling Wang; S Diane Hayward; Gary S Hayward
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

9.  Alterations of the MDV oncogenic regions in an MDV transformed lymphoblastoid cell line.

Authors:  E Le Rouzic; P Thoraval; M Afanassieff; Y Cherel; G Dambrine; B Perbal
Journal:  Mol Pathol       Date:  2002-08

Review 10.  Retrotransposition and herpesvirus evolution.

Authors:  P Brunovskis; H J Kung
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.